NIMC
LFCR icon

NWQ Investment Management Company’s Lifecore Biomedical LFCR Stock Holding History

NWQ Investment Management Company’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$5.37M Sell
552,537
-340,589
-38% -$3.24M 0.24% 101
2020
Q2 		$7.11K Sell
893,126
-1,035,545
-54% -$10.7M 0.24% 91
2020
Q1 		$16.8M Sell
1,928,671
-179,923
-9% -$1.87M 0.67% 56
2019
Q4 		$23.8M Sell
2,108,594
-591,017
-22% -$6.29M 0.59% 68
2019
Q3 		$29.3M Sell
2,699,611
-722,355
-21% -$7.86M 0.71% 59
2019
Q2 		$32.1M Sell
3,421,966
-215,255
-6% -$2.17M 0.72% 61
2019
Q1 		$44.7M Buy
3,637,221
+1,069
+0% +$13.1K 0.97% 34
2018
Q4 		$43.1M Buy
3,636,152
+140,047
+4% +$1.92M 1.02% 30
2018
Q3 		$47.6M Buy
3,496,105
+39,835
+1% +$551K 0.94% 37
2018
Q2 		$51.5M Sell
3,456,270
-89,985
-3% -$1.25M 0.93% 35
2018
Q1 		$46.3M Sell
3,546,255
-154,333
-4% -$2.03M 0.75% 54
2017
Q4 		$46.6M Sell
3,700,588
-78,635
-2% -$994K 0.61% 62
2017
Q3 		$48.9M Buy
3,779,223
+53,050
+1% +$699K 0.6% 60
2017
Q2 		$55.3M Buy
3,726,173
+17,765
+0.5% +$247K 0.77% 53
2017
Q1 		$44.5M Buy
3,708,408
+687,199
+23% +$8.7M 0.59% 75
2016
Q4 		$41.7M Sell
3,021,209
-60,225
-2% -$834K 0.57% 80
2016
Q3 		$41.3M Buy
3,081,434
+229,584
+8% +$2.78M 0.6% 70
2016
Q2 		$30.7M Buy
2,851,850
+367,281
+15% +$4.05M 0.53% 77
2016
Q1 		$26.1M Buy
2,484,569
+155,629
+7% +$1.71M 0.41% 86
2015
Q4 		$27.6M Buy
2,328,940
+617,110
+36% +$7.58M 0.43% 84
2015
Q3 		$20M Buy
1,711,830
+172,610
+11% +$2.29M 0.31% 93
2015
Q2 		$22.2M Buy
1,539,220
+9,540
+0.6% +$138K 0.31% 94
2015
Q1 		$21.3M Buy
1,529,680
+185,608
+14% +$2.56M 0.27% 91
2014
Q4 		$18.6M Buy
1,344,072
+476,890
+55% +$6.16M 0.22% 97
2014
Q3 		$10.6M Buy
+867,182
New +$10.8M 0.12% 112

Other funds holding LFCR

LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

NWQ Investment Management Company's LFCR Position: Q3 2020 in Review

NWQ Investment Management Company reduced its Lifecore Biomedical (LFCR) stake by 38% in Q3 2020, selling an estimated $3.24M and leaving 552,537 shares worth $5.37M. The position accounts for 0.24% of the portfolio, ranked #101.

NWQ Investment Management Company first reported a position in LFCR in Q3 2014 and has held it in 25 quarters since. The position peaked at $55.3M in Q2 2017. 96 funds tracked by Wall St. Rank hold LFCR as of Q3 2020.

  • NWQ Investment Management Company held 552,537 shares of Lifecore Biomedical worth $5.37M as of Q3 2020.
  • NWQ Investment Management Company sold 340,589 Lifecore Biomedical shares in Q3 2020, an estimated $3.24M.
  • Lifecore Biomedical made up 0.24% of NWQ Investment Management Company's portfolio in Q3 2020, its #101 holding.
  • NWQ Investment Management Company first reported a position in Lifecore Biomedical in Q3 2014 and has held it in 25 quarters since.
  • NWQ Investment Management Company's Lifecore Biomedical position peaked at $55.3M in Q2 2017.
  • 96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.